Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

RQM+ Announces Investment by Linden Capital Partners

publication date: Aug 25, 2021
 | 
author/source: RQM+

rqm-announces-investment-linden-capital-partners

 

Investment to Accelerate Growth and Expand Consulting Services for Medical Device and Diagnostics Manufacturers

RQM+ has announced an investment by Linden Capital Partners (Linden), a Chicago-based healthcare private equity firm. Headquartered in Monroeville, PA, a suburb of Pittsburgh, RQM+ is the largest international provider of regulatory, quality and compliance consulting services dedicated to medical device and in-vitro diagnostics manufacturers.

Maria Fagan, CEO of RQM+, stated, “We are extremely proud of the business we have built at RQM+ and excited to partner with Linden to accelerate our growth and expand the breadth of services we can provide to our customers. We chose the Linden team as our partner for the next phase of our growth due to their exclusive focus on healthcare investing and shared vision for RQM+.”

Richard Thomas, incoming board member of RQM+ and industry veteran, said, “We commend Maria Fagan, Lisa Casavant and the entire management team at RQM+ on building an extraordinary business providing superior quality and services that are essential to helping their clients navigate a dynamic and increasing complex regulatory landscape. As manufacturers accelerate product and technology innovation to meet future healthcare needs, RQM+ is uniquely positioned to support the industry with an expanding suite of end-to-end capabilities and approaches to strategic partnership.”

Michael Farah, a Partner at Linden and incoming board member of RQM+, added, “Our investment in RQM+ is a direct result of our dedicated and longstanding outsourced medical device services sector effort, and we are excited to partner with an organization with such a strong market reputation in a highly fragmented industry. We look forward to supporting the entire RQM+ team as they seek to grow both organically and through acquisitions.” 

Members of the RQM+ leadership team have long-tenured careers rooted in medical device product development.  This powerhouse team has led the company’s growth to:

  • Over 400 employees and multiple offices across the U.S. and Europe,
  • Remarkably high customer and employee retention rates,
  • A one-of-a-kind caring and empowering culture that attracts the industry’s best talent, and
  • The strongest reputation for client satisfaction in the industry, as confirmed by net promoter score client surveys to the world’s largest multinational medical device and IVD manufacturers.

In assessing partners, Fagan also said, “The RQM+ leadership team sought out a partner that was both focused on healthcare and supportive of our continued, intense focus on our core values. Maintaining an incredible culture for employees and delivering innovative solutions to our clients to ensure medical devices reach the patients who need them is what RQM+ is all about. We found Linden to be perfectly aligned to these same core values.”

 

About RQM+

RQM+ is the leading international provider of regulatory, quality and compliance consulting services for medical device and diagnostics manufacturers. The company delivers transformative solutions by providing unrivaled collective expertise fueled by passion for client success. The experts at RQM+ are collaborative, laser-focused on client needs and committed to delivering high-value solutions that exceed expectations.

 

About Linden Capital Partners

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating experience, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies.

 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners